Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea
· Delayed Price · Currency is KRW
90,000
-1,500 (-1.64%)
Apr 29, 2026, 2:40 PM KST
Orum Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,942,762 | 2,547,884 | - | - | - |
| Enterprise Value | 1,835,659 | 2,429,338 | - | - | - |
| Last Close Price | 91500.00 | 120000.00 | - | - | - |
| PS Ratio | 82445.37 | 108125.08 | - | - | - |
| PB Ratio | 14.84 | 19.47 | - | - | - |
| P/TBV Ratio | 14.84 | 19.47 | - | - | - |
| EV/Sales Ratio | - | 103094.30 | - | - | - |
| Debt / Equity Ratio | 0.20 | 0.20 | 0.23 | 0.20 | 0.24 |
| Debt / EBITDA Ratio | - | - | - | 0.27 | - |
| Debt / FCF Ratio | - | - | - | 0.28 | - |
| Net Debt / Equity Ratio | -0.82 | -0.82 | -0.74 | -0.78 | -0.89 |
| Net Debt / EBITDA Ratio | 2.21 | 2.21 | 16.55 | -1.03 | 0.22 |
| Net Debt / FCF Ratio | 2.92 | 2.92 | 7.21 | -1.08 | 0.23 |
| Asset Turnover | 0 | 0 | 0.13 | 1.48 | - |
| Quick Ratio | 8.52 | 8.52 | 3.81 | 13.92 | 1.36 |
| Current Ratio | 8.61 | 8.61 | 3.85 | 13.95 | 1.42 |
| Return on Equity (ROE) | -33.22% | -33.22% | -4.57% | 97.53% | - |
| Return on Assets (ROA) | -20.02% | -20.02% | -3.30% | 65.28% | - |
| Return on Capital Employed (ROCE) | -33.70% | -33.70% | -6.80% | 62.60% | -353.10% |
| Earnings Yield | -2.16% | -1.65% | - | - | - |
| FCF Yield | -1.89% | -1.44% | - | - | - |
| Buyback Yield / Dilution | -53.70% | -53.70% | 10.08% | -227.30% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.